Predicting readmission risk following percutaneous coronary intervention at the time of admission

Nov 13, 2017 by in CARDIOLOGY Comments Off on Predicting readmission risk following percutaneous coronary intervention at the time of admission

Abstract Objective To investigate whether a prediction model based on data available early in percutaneous coronary intervention (PCI) admission can predict the risk of readmission. Background Reducing readmissions following hospitalization…

read more

A comparison of cangrelor, prasugrel, ticagrelor, and clopidogrel in patients undergoing percutaneous coronary intervention: A network meta-analysis

Nov 13, 2017 by in CARDIOLOGY Comments Off on A comparison of cangrelor, prasugrel, ticagrelor, and clopidogrel in patients undergoing percutaneous coronary intervention: A network meta-analysis

Abstract Background Newer P2Y12 inhibitors have more rapid onset of platelet inhibition compared with clopidogrel, especially the intravenous P2Y12 inhibitor cangrelor. Direct comparisons between cangrelor and oral P2Y12 inhibitors ticagrelor…

read more

Integrating local data into readmission risk prediction

Nov 13, 2017 by in CARDIOLOGY Comments Off on Integrating local data into readmission risk prediction

Over nearly a decade, we have made substantial progress in predicting, understanding, and preventing hospital readmission following percutaneous coronary intervention (PCI). In 2007, the Medicare Payment Advisory Commission (MedPAC) noted…

read more
Get Clinical Tree app for offline access